Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Acute bronchospasm during passive exposure to bronchial provocation tests

Maria Gabrovska, Emmanuel Lacombe, Marie Bruyneel, Vincent Ninane
European Respiratory Journal 2016 47: 320-322; DOI: 10.1183/13993003.00039-2015
Maria Gabrovska
Chest Service, Saint-Pierre University Hospital, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: maria_gabrovska@stpierre-bru.be
Emmanuel Lacombe
Chest Service, Saint-Pierre University Hospital, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Bruyneel
Chest Service, Saint-Pierre University Hospital, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Ninane
Chest Service, Saint-Pierre University Hospital, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

No need for bronchial challenge testing in asymptomatic technicians commencing work in a lung function department http://ow.ly/S2D3z

To the Editor:

Bronchial challenge with direct stimuli, like histamine and methacholine, is very sensitive for diagnosing asthma and produces similar responses on a milligram-on-milligram or on a millimole-on-millimole basis [1–4]. American Thoracic Society (ATS)/European Respiratory Society (ERS) guidelines have proposed measures in order to protect technicians performing these tests, which include the use of good filters and ventilation, and have recommended that technicians with asthma should take extra precautions to minimise exposure or should avoid challenge testing. Performing methacholine/histamine challenge tests on technicians has also been thought to be useful [1]. Evidence however remains limited with only three published papers reporting some reaction to passive exposure in technicians [5–7], with two of these cited in the ATS/ERS guidelines [1]. One was a survey that only reported technicians' symptoms during challenge tests [5], another described two nurses who developed increased airway responsiveness after 2 years of regular practice of histamine and methacholine challenge tests, and the third paper reported episodic bronchospasm in a female technician known to have stable and well-treated asthma [7].

We have prospectively investigated the risk of acute bronchospasm during passive exposure to histamine. We invited symptomatic patients with newly diagnosed high levels of bronchial hyperreactivity (PD20 (provocative concentration causing a 20% fall in forced expiratory volume in 1 s) at first histamine dose) to agree to be passively exposed to histamine within 7 days of their first test in a manner comparable to the technician's passive exposure. We reasoned that if these patients showed no response to passive exposure, then the risk to asymptomatic technicians would be very small. The study was approved by the ethics committee (Saint-Pierre University Hospital, Brussels, Belgium) and participants filled in an informed consent form. For this exploratory and mainly descriptive study, a sample size of 12 patients was considered sufficient and the study was registered (NCT01937494).

13 adult patients with symptoms (i.e. dyspnoea, non-productive cough, chest tightness and wheezing) not diagnostic for asthma, and positive histamine provocation test at first dose were included. None of them received asthma treatment. During the diagnostic test, the patient was seated in the body box cabin whose door remained open. The technician remained close to the cabin (about 1 m). In addition to the expiratory filter, a standard ventilation system was present in the room whose approximate surface area was 4 m². During the passive exposure test, the patients remained close to the technician, while the subjects actively exposed were now volunteers with previously known negative results.

The conventional 2-min tidal breathing histamine challenge test protocol was followed using Jaeger APS Pro (ERICH Jaeger GmbH, Wurzburg, Germany) and DeVilbiss 646 (Sunrise Medical HHG Inc., Somerset, PA, USA) jet nebuliser with an output of 900 µL·min−1 and a distribution range of 2.1 µm [1, 3]. The expiratory filter was always changed after four challenge tests. We used a short protocol of five concentrations (0.9% saline as initial baseline control, histamine 1 and/or 2 mg·mL−1, 4, 8, 16 and 32 mg·L−1) with the 1 mg·mL−1 concentration being usually given to patients with the highest suspicion of severe bronchial hyperreactivity [1, 8]. The forced expiratory volume in 1 s (FEV1) was obtained at each step about 30 and 90 s after nebulisation and the test was stopped if the FEV1 fall was equal to or exceeded 20% of baseline FEV1. The corresponding dose for a 20% decrease in FEV1 (PD20) was then calculated and the results of active and passive exposure were compared.

13 patients (12 female) with normal FEV1 to forced vital capacity ratio (standardised residuals, z-scores, between −1.630 and 0.260) [9, 10] and no contraindication to histamine challenge test [1] were included.

Symptoms at presentation included dyspnoea in 10 (77%), cough in eight (62%), chest tightness in two (15%) and wheezing in two (15%) patients. During active exposure to histamine, a positive reaction at the first dose was observed in all included patients with a PD20 <60 µg and a mean±sd FEV1 fall amounting to 830±270 mL. During passive exposure, no reaction was observed in 12 (92%) of the patients; one patient had a very mild reaction with a PD20 at 614 µg (at a concentration of 16 mg·mL−1 of histamine) (figure 1). None of the study patients felt chest tightness or showed cough during the passive exposure. No relationship appeared between the PD20 of the first diagnostic test and the passive PD20 or the last used dose without reaction of the passive test.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Results of the passive histamine challenge test with the subject's number on the x-axis and, on the y-axis, the subjects' percentage change in forced expiratory volume in 1 s (FEV1) on completion of the test. The final dose of histamine (in µg) is plotted for each subject. Only one subject (number 4) had a significant response with >20% fall of FEV1 at a PD20 of 614 µg (891 µg total dose of histamine received). See text for further explanation.

These data show that symptomatic subjects with reaction to lowest doses during histamine challenge test show an absence of clinically significant response when they are exposed to histamine in conditions mimicking those of laboratory technicians performing the test. In contrast with previous studies that suggested a risk associated with passive exposure [5–7], mouthpiece and box valve on the expired side as well as adequate ventilation that minimised the exposure were used [2, 11]. The study from Lundgren et al. [6] also suggested that repeated passive exposure may lead to airway hyperreactivity. This is however in contradiction with previous findings in asthmatic patients showing that histamine provocation tests can be repeated without the appearance of tachyphylaxis or increased sensitivity to histamine [12].

Finally, the absence of response to passive exposure in symptomatic highly hyperreactive patients suggests that there is no need for a previous challenge testing in asymptomatic technicians starting to work in a lung function department.

Footnotes

  • Clinical trial: This study is registered at ClinicalTrials.gov with identifier number NCT01937494.

  • Conflict of interest: None declared.

  • Received January 10, 2015.
  • Accepted July 24, 2015.
  • Copyright ©ERS 2016

References

  1. ↵
    1. Carpo RO,
    2. Casaburi R,
    3. Coates AL, et al.
    Guidelines for methacholine and exercise challenge testing – 1999. Am J Respir Crit Care Med 2000; 161: 309–329.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Cockroft DW
    . Bronchoprovocation methods: direct challenges. Clin Rev Allergy Immunol 2003; 24: 19–26.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Cockroft DW
    . Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138: Suppl. 2, S18–S24.
    OpenUrl
  4. ↵
    1. Higgins BG,
    2. Britton JR, et al.
    Comparison of histamine and methacholine for use in bronchial challenge tests in community studies. Thorax 1988; 43: 605–610.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Shapiro GG,
    2. Simon RA
    . Bronchoprovocation committee report. J Allergy Clin Immunol 1992; 89: 775–778.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Lundgren R,
    2. Söderberg M,
    3. Rosenhall L, et al.
    Development of increased airway responsiveness in two nurses performing methacholine and histamine challenge tests. Allergy 1992; 47: 188–189.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Sen RP,
    2. Walsh TE
    . Accidental methacholine bronchoprovocation in a laboratory worker. Chest 1991; 99: 1053–1054.
    OpenUrlPubMed
  8. ↵
    1. Sterk PJ,
    2. Fabbri LM,
    3. Quanjer PH, et al.
    Airway Responsiveness: Standardised challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993; 6: Suppl. 16, 53–83.
    OpenUrl
  9. ↵
    1. Quanjer PH,
    2. Stanojevic S,
    3. Cole TJ, et al.
    Multi-ethnic reference values for spirometry for the 3–95 year age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324–1343.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Miller MR
    . Does the use of per cent of predicted have any evidence base? Eur Respir J 2015; 45: 322–323.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Juniper EF,
    2. Syty-Golda M,
    3. Harggreave FE
    . Histamine inhalation tests: inhalation of aerosol via a facemask versus a valve box with mouthpiece. Thorax 1984; 39: 556–557.
    OpenUrlFREE Full Text
  12. ↵
    1. Ruffin RE,
    2. Alpers JH,
    3. Cockett AJ, et al.
    Repeated histamine inhalation tests in asthmatic patients. J Allergy Clin Immunol 1981; 67: 285–289.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
View this article with LENS
Vol 47 Issue 1 Table of Contents
European Respiratory Journal: 47 (1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Acute bronchospasm during passive exposure to bronchial provocation tests
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Acute bronchospasm during passive exposure to bronchial provocation tests
Maria Gabrovska, Emmanuel Lacombe, Marie Bruyneel, Vincent Ninane
European Respiratory Journal Jan 2016, 47 (1) 320-322; DOI: 10.1183/13993003.00039-2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Acute bronchospasm during passive exposure to bronchial provocation tests
Maria Gabrovska, Emmanuel Lacombe, Marie Bruyneel, Vincent Ninane
European Respiratory Journal Jan 2016, 47 (1) 320-322; DOI: 10.1183/13993003.00039-2015
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Lung structure and function
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • D-dimer cut-offs and machine learning for ruling out pulmonary embolism
  • Sputum cell counts in COPD patients who use electronic cigarettes
  • Extracorporeal life support allows lung transplant in rapidly progressive ILD
Show more Agora

Research letters

  • D-dimer cut-offs and machine learning for ruling out pulmonary embolism
  • Sputum cell counts in COPD patients who use electronic cigarettes
  • Extracorporeal life support allows lung transplant in rapidly progressive ILD
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society